WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Pharmaceutical Exporter from India to Morocco.

Morocco runs a mature pharmaceutical market with a strong domestic industry, so an Indian supplier earns shelf space by filling the gaps local manufacturers do not cover: oncology biosimilars, second-line anti-infectives, paediatric formulations in scarce strengths, and cold-chain biologics. M Care Exports works alongside Moroccan importers and private hospital groups, prepares French CTD dossiers for the Agence marocaine des médicaments et des produits de santé (AMMPS), and routes shipments through Tanger Med, Africa's largest container port, or by air into Casablanca, with the batch paperwork ready before arrival.

WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners ISO 9001:2015 SGS GDP Certified Pharmexcil RCMC FIEO Member Cold-chain validated CTD / eCTD ready
Regulatory environment

The regulator, the dossier and lot release in Morocco

Morocco's medicines regulator is the Agence marocaine des médicaments et des produits de santé (AMMPS), created under Law 10.22; its first board meeting, chaired by the Head of Government in January 2025, adopted the agency's programme, budget and organisation. The agency has taken over the regulatory work of the Ministry of Health's Direction du médicament et de la pharmacie (DMP). We prepare Moroccan dossiers in CTD format and in French, and confirm the current language, sample and batch-testing requirements with the agency for each file. The time to authorisation varies with the product and the completeness of the file, so we give an estimate for each molecule at enquiry.

We translate every CTD module into regulatory French rather than commercial French, and we hold the certificates of pharmaceutical product, GMP attestations, and free-sale certificates from the Indian regulator that a Moroccan dossier needs as Module 1 annexes.

Lot release checks depend on the product and the current Moroccan rules, so we confirm with the importer what the national laboratory will ask for on each lot. We send the certificate of analysis with chromatograms, dissolution profiles and impurity data before the shipment arrives, and for biologics and other cold-chain products the stability data and the shipment's temperature logs as well.

We invoice in EUR or USD against a letter of credit from a Moroccan bank, confirmed where the buyer asks, and prepare every document to the credit's exact terms so payment is not held up by discrepancies.

Call & WhatsApp the Mumbai desk: +91 70156 05768 · [email protected] · Mon–Sat 09:30–18:30 IST

What we do for Moroccan customers

Six work-streams that make a Moroccan import file move

AMMPS dossier preparation in regulatory French

We build Module 1 to Module 5 of the Common Technical Document in French, with every Indian regulator certificate, GMP attestation, and stability summary translated. We close gaps in advance: legalised CPP, Apostille on Indian documents, manufacturer site-master file extracts, and the French summary of product characteristics.

Oncology and biologics specialised supply

Moroccan local manufacturing has limited oncology and biologic depth, which is where Indian biosimilars and complex generics carry real institutional value. We supply trastuzumab, rituximab, bevacizumab, and the cytotoxic injectable backbone, plus targeted therapies in tablet form, into CHU oncology day-care centres at Rabat, Casablanca, and Marrakech with documented cold-chain integrity from our Mumbai depot through to Casablanca pharmacy receipt.

CHU tender response packs

Moroccan university hospital centres (CHU) buy through their own calls for tender, each with its own document checklist. We build the response pack to the call for the procurement office at Ibn Sina, Ibn Rochd, Mohammed VI, Hassan II or Mohammed VI Oujda, with the Indian manufacturing file, samples where requested and a supply commitment.

Tanger Med and Casablanca freight execution

Tanger Med handled more than 10 million TEU in 2024 and is the usual gateway for ambient containers from Mumbai. Cold-chain biologics usually travel by air into Casablanca, and we keep both options live so a customer does not lose a quarter to a single-port disruption. Documentation moves to the importer ahead of the shipment.

LNCM batch-release coordination

Once a container lands, the importer handles any laboratory release the lot needs. We pre-position the analytical evidence the laboratory will request: HPLC chromatograms for assay and related substances, dissolution profiles for solid orals, sterility and endotoxin results for parenterals, and stability summary tables that match the dossier on file. The aim is a release decision without weeks of back-and-forth.

Private hospital and retail-chain supply

Outside the CHU system, Moroccan private hospital groups and the larger retail-pharmacy chains buy through licensed importers under their own commercial terms. We support importer-led private channel supply with monthly demand visibility, lot-traceable invoicing, EUR-denominated commercial documentation, and consolidated air-freight options for short-shelf-life or smaller-volume cold-chain lines.

Mumbai to Maghreb routing

How a container moves from our Mumbai depot to a Moroccan importer

Sea freight from Jawaharlal Nehru Port at Mumbai reaches Tanger Med through the Suez Canal; transit time depends on the carrier's routing and transhipment port, and we confirm it at booking. We pre-clear customs documentation with the Moroccan importer before the vessel berths so the container moves to bonded warehouse on the day of discharge rather than sitting under terminal demurrage.

Cold-chain consignments move in reefer containers with data loggers, and we audit the first leg from the Mumbai cold room to the load port so the chain does not break. For oncology biologics with tighter stability windows we offer air freight into Casablanca in active temperature-controlled containers.

Commercial paperwork is built around EUR or USD invoices, the letter of credit from the Moroccan bank, and the import documents the Moroccan importer holds for the product. We provide certificates of analysis batch by batch, the manufacturer free-sale certificate, the certificate of origin attested by the Indian chamber, and any French translation the customs file requires, all packaged ahead of arrival.

Formulary focus

Where Indian supply earns its place on the Moroccan shelf

The Moroccan formulary is heavily occupied by domestic manufacturers and European originators, so an Indian exporter wins by going where neither plays at scale: oncology biosimilars priced for sustained CHU consumption, second-line and last-line anti-infectives, paediatric strengths the local industry skips, anti-retroviral combinations under national HIV programme tenders, and complex generics that require CDMO-grade analytical depth. We curate our Morocco file around exactly those gaps.

Cardiovascular and diabetes therapy areas function as steady-volume backbones, but the differentiating value for a Moroccan buyer is in the niche: tacrolimus for transplant centres, immunosuppressants for nephrology, scarce-strength epilepsy molecules, and oncology supportive care including bone-modifying agents and targeted antiemetics. Each of these lines benefits from a documented Indian manufacturing source with EU-GMP or PIC/S exposure that the regulator can verify through the certificate of pharmaceutical product.

Respiratory and CNS lines round out the Morocco shelf where the buyer wants brand reliability without the European originator price. We source inhalation, anti-asthma, and antipsychotic formulations from WHO-GMP certified Indian manufacturers, and where a site holds EDQM, MHRA or USFDA inspection history we put it in the file, which gives a Moroccan importer a clear answer when a procurement committee asks why an Indian source belongs on a CHU tender award.

A Casablanca-based licensed importer was building a tender response for a CHU oncology day-care centre that needed a stable trastuzumab supply across a twelve-month award. The originator price had pushed the centre to look at biosimilar options, but the importer had been burned earlier by a partner who could not produce LNCM-grade analytical data. We mobilised in four weeks: a Module 3 quality file translated into French by our regulatory desk, batch chromatograms and the comparative bioassay summary from the Indian manufacturer, three pre-validation samples flown to LNCM under active-temperature container, and a CHU pack that detailed our Mumbai cold-room loading protocol and Tanger Med routing alternative. The award came through. Container one cleared LNCM batch validation inside the published service standard, the second container shipped on schedule, and the importer extended the working file to a second biosimilar molecule before the first quarter closed. The win for the customer was not a price line. It was that every piece of paper the Moroccan reviewer asked for arrived ready, in the right language, in the right format.

Illustrative operational case Morocco · Casablanca licensed importer · Oncology biosimilars
Why Moroccan importers select M Care

An Indian export desk that knows the Moroccan file

Most Indian exporters approach Morocco the way they approach any French-speaking African market, with a one-page price list and a hopeful CPP. Morocco does not work that way. The regulator wants a complete French dossier, the national laboratory wants analytical evidence that ties each batch to the registered file, and CHU procurement committees want a supply commitment that holds once a molecule is awarded. We build each Morocco file for those three audiences in parallel.

The other piece is the local-industry context. Moroccan manufacturing is real and well organised. An Indian exporter who tries to compete head-on with a domestic manufacturer on a paracetamol or amoxicillin file will spend a budget and lose. We position our Morocco book on the niche side: oncology biosimilars, biologics, complex generics, paediatric strengths and transplant medicines, where local manufacturers do not cover demand. That is the segment where a Moroccan importer who works with us can build a specialty book rather than a commodity book.

Morocco FAQ

What Moroccan procurement teams ask before they place a Mumbai order

Does M Care prepare the French-language CTD dossier for AMMPS, or do we contract that separately?

We prepare the full French-language Common Technical Document in-house through our regulatory desk, including Module 1 administrative annexes, Module 2 quality and clinical summaries, and Module 3 quality data, translated from the Indian manufacturer's master file. Most Moroccan importers work with us under a single commercial agreement that bundles the dossier and the supply commitment, so they do not have to manage a second consultant invoice or coordinate document handover between two parties.

How long does a Moroccan marketing authorisation take?

It varies with the product and how complete the file is, so we give an estimate for each molecule at enquiry. Stability supplements, a manufacturing site not inspected by an EU-recognised regulator, or analytical-method questions all add time. We try to flag those risks during the gap analysis we run before filing rather than after the dossier enters review.

Can a Moroccan licensed importer place a single-molecule order, or is there a minimum portfolio?

Single-molecule orders are common, particularly for oncology biosimilars and biologics where the importer is responding to a specific CHU tender award rather than building a broad book. We have no minimum portfolio requirement and no minimum order value beyond what makes commercial sense for a temperature-controlled shipment. For ambient solid orals we typically consolidate into a forty-foot container or a partial reefer, and for cold-chain biologics we run scheduled air freight at the volume the institutional customer needs.

Which Moroccan port should we route an ambient pharmaceutical container through, Tanger Med or Casablanca?

Tanger Med, which handled more than 10 million TEU in 2024, is the usual gateway for ambient containers from Mumbai. Casablanca sits closer to the main distribution centres and is the usual entry for air freight, which is how most cold-chain biologics travel. We keep both options available on every shipment so a disruption at either port does not delay an importer's release schedule.

How does lot release work in Morocco?

Release checks depend on the product and the current Moroccan rules, so we confirm with the importer and the regulator what the national laboratory will ask for on each lot. We pre-position the certificate of analysis and the analytical evidence the laboratory references, so the lot is not held for a re-test.

What therapeutic areas does M Care prioritise for Morocco rather than competing with local manufacturers?

Oncology biosimilars, biologics, complex generics, second-line and last-line anti-infectives, transplant immunosuppressants, paediatric scarce strengths, and cold-chain biologics including insulins. These are the segments where Moroccan domestic manufacturing either has limited analytical depth or has not invested behind the molecule, which gives an Indian WHO-GMP supplier a defendable formulary position. We deliberately stay light on commodity solid orals where local manufacturers have a structural cost and political advantage, because that is not a market segment a foreign exporter wins on.

What banking and currency arrangements does M Care use for Morocco shipments?

We invoice in EUR or USD against an irrevocable letter of credit issued by a Moroccan commercial bank, confirmed where the importer requests it, and prepare the documents to the credit's exact terms. For repeat customers with a working-credit history we move to documents-against-payment or open-account terms once a track record is established.

Indian pharmaceutical supply built for Morocco

Open a Moroccan working file with a Mumbai desk that knows AMMPS

Complete French CTD

Module 1 to Module 5 prepared in regulatory French, with Indian regulator certificates, GMP attestations, and stability summaries in the file from the first submission.

Tanger Med plus Casablanca

Both Moroccan port options kept live on every shipment, with pre-cleared importer paperwork and active-temperature container routing for cold-chain biologics moving into CHU oncology centres.

Specialty-first formulary

Oncology biosimilars, biologics, transplant immunosuppressants, paediatric scarce strengths, second-line anti-infectives. The shelf segments Moroccan local manufacturers do not cover.

Shop by therapeutic area

Top categories we ship to Morocco

Start a Moroccan file

Send the molecule list. We send back an AMMPS filing plan.

Share the Moroccan importer name, the molecules under consideration, and the CHU or private channel target. Within five working days we return a gap analysis against the existing registration file, a French-CTD preparation plan with timeline, an LNCM validation strategy, and a Tanger Med or Casablanca routing recommendation. No upfront commitment. The plan tells you what filing in Morocco actually costs in time and document work, so the commercial decision is informed before any dossier work starts.

Start a Morocco enquiry → Back to all markets

Buying for repeat supply? Open a trade account for a named account manager and priced quotes.